FRANCISCO
VANACLOCHA SEBASTIÁN
Investigador no período 2009-2016
Baylor University Medical Center
Dallas, Estados UnidosPublicacións en colaboración con investigadores/as de Baylor University Medical Center (1)
2017
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 10, pp. 1693-1699